Works matching IS 08991987 AND DT 2023 AND VI 62 AND IP 3

Results: 10

DDIT4 promotes malignancy of head and neck squamous cell carcinoma.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 332, doi. 10.1002/mc.23489

By:

Zhang, Zhenxing;
Zhu, Haoran;
Zhao, Chifeng;
Liu, Dong;
Luo, Jun;
Ying, Yukang;
Zhong, Yuan

Publication type:

Article

Serum lncRNAs, NBAT‐1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 319, doi. 10.1002/mc.23488

By:

Ali, Marwa A.;
Shaker, Olfat G.;
Ezzat, Eman M.;
Eid, Hanaa M.;
Ali, Doaa Y.;
Hassan, Essam A.;
Elsayed, Dalia H.;
Abozaid, Eman R.;
Abdelaleem, Omayma O.

Publication type:

Article

UHRF1 plays an oncogenic role in small cell lung cancer.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 385, doi. 10.1002/mc.23493

By:

Hou, Jia;
Li, Wenyuan;
Zhang, Shirong;
Tan, Deli;
Lv, Kejia;
Zhu, Yue;
Hou, Yuzhu;
Guo, Hui;
Jiang, Lili

Publication type:

Article

Circ‐E‐Cad encodes a protein that promotes the proliferation and migration of gastric cancer via the TGF‐β/Smad/C‐E‐Cad/PI3K/AKT pathway.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 360, doi. 10.1002/mc.23491

By:

Li, Fanying;
Tang, Hongxing;
Zhao, Shaoji;
Gao, Xinya;
Yang, Lixuan;
Xu, Jianbo

Publication type:

Article

Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF‐β1/pERK signaling pathway.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 398, doi. 10.1002/mc.23494

By:

Deza, Zahira;
Caimi, Giselle Romero;
Noelia, Miret;
Coli, Lucia;
Ridruejo, Ezequiel;
Alvarez, Laura

Publication type:

Article

KIN17 promotes cell migration and invasion through stimulating the TGF‐β/Smad2 pathway in hepatocellular carcinoma.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 369, doi. 10.1002/mc.23492

By:

Dai, Zichang;
Huang, Qiyuan;
Huang, Xueran;
Zhu, Chuiyu;
Zahid, Kashif Rafiq;
Liu, Tiancai;
Li, Qiuyan;
Wu, Chunmei;
Peng, Minghui;
Xiao, Xiangyan;
Raza, Umar;
Yu, Nan;
Zeng, Tao

Publication type:

Article

Somatic A‐to‐I RNA‐edited RHOA isoform 2 specific‐R176G mutation promotes tumor progression in lung adenocarcinoma.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 348, doi. 10.1002/mc.23490

By:

Chen, Kuan‐Ju;
Huang, Jing‐Hsiang;
Shih, Jou‐Ho;
Gu, De‐Leung;
Lee, Szu‐Shuo;
Shen, Roger;
Hsu, Yu‐Hsuan;
Kung, Ying‐Chih;
Wu, Cheng‐Yen;
Ho, Chun‐Ming;
Jen, Hsin‐Wei;
Lee, Hsin‐Yi;
Lang, Yaw‐Dong;
Hsiao, Chen‐Hao;
Jou, Yuh‐Shan

Publication type:

Article

Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 293, doi. 10.1002/mc.23486

By:

Wang, Xiwei;
Zheng, Yingying;
Chai, Zhengbin;
Li, Ji;
Zhu, Changhui;
Peng, Yanling;
Qiu, Juanjuan;
Xu, Jiajun;
Liu, Chunyan

Publication type:

Article

KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 303, doi. 10.1002/mc.23487

By:

Zhang, Jun;
An, Lanfen;
Zhao, Rong;
Shi, Rui;
Zhou, Xing;
Wei, Sitian;
Zhang, Qi;
Zhang, Tangansu;
Feng, Dilu;
Yu, Zhicheng;
Wang, Hongbo

Publication type:

Article

Issue Information ‐ Ed Board.

Published in:: Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 289, doi. 10.1002/mc.23425
Publication type:: Article